PYXS Pyxis Oncology Inc
Company Analysis
Latest News
🟢 Pyxis Oncology is trading 6.75% up in pre-market amid possible H.C. Wainwright event anticipation
Pyxis Oncology is trading 6.75% up at $3.43, with no clearly identified overnight company announcement explaining the September 14, 2026 pre-market move. -...
🔴 Pyxis Oncology is trading 5.2% down today after MICVO confirmed response rate fell to 36%
Pyxis Oncology is trading 5.2% down at $3.10 after updated MICVO Phase 1 data showed a 36% confirmed response rate among 33 evaluable patients, versus 46%...
🔴 Pyxis Oncology is trading 5.18% down today after MICVO response rate fell to 36%
Pyxis Oncology is trading 5.18% down at $3.21 after updated Phase 1 MICVO data showed a 36% confirmed response rate among 33 evaluable patients. - The...
🔴 Pyxis Oncology is trading 11% down today after confirmed response rate fell to 36%
Pyxis Oncology is trading 11.05% down now at $3.46 after updated Phase 1 MICVO data showed a 36% confirmed response rate in 33 evaluable patients. - The...
Pyxis Oncology's MICVO Shows 36% Response Rate in Phase 1 Head & Neck Cancer Trial
Pyxis Oncology announced positive updated data from its ongoing global Phase 1 monotherapy study of its lead drug candidate, micvotabart pelidotin (MICVO). The...
🔴 Pyxis Oncology is trading 8.74% down today after updated MICVO data showed 36% response rate
Pyxis Oncology is trading 8.74% down at $3.55 after releasing updated Phase 1 monotherapy data for MICVO in recurrent/metastatic head and neck cancer following...
🔴 Pyxis Oncology is trading 21.34% down in pre-market
Pyxis Oncology is trading 21.34% down at $3.06 in pre-market after closing at $3.89 on September 8, 2026. - The company scheduled a 7:30 a.m. ET webcast for...
🟢 Pyxis Oncology is trading 5% up in pre-market after announcing September 9 MICVO data webcast
Pyxis Oncology is trading 5.4% up now at $4.10 after announcing a September 9, 2026, webcast at 7:30 a.m. ET presenting updated Phase 1 MICVO data in...
Pyxis Oncology Locks In Its CEO and Bets the House on Tomorrow's Data — But Can a $290 Million Biotech Survive the Wait?
Shares of Pyxis Oncology jumped 10% to $4.28 after the company ended a seven-month leadership search by making interim chief Thomas Civik permanent CEO and...
🟢 Pyxis Oncology is trading 10% up in after-hours trading after naming Thomas Civik CEO and chairman
Pyxis Oncology is trading 10.01% up at $4.28 in after-hours trading after announcing Thomas Civik’s appointment as permanent CEO and chairman, effective...
🟢 Pyxis Oncology is trading 6.17% up in after-hours trading after appointing Thomas Civik CEO and chairman
Pyxis Oncology is trading 6.17% up in after-hours trading at $4.13 after announcing Thomas Civik’s appointment as permanent CEO and chairman, effective...
Pyxis Oncology Appoints Interim CEO Thomas Civik as Permanent CEO and Chairman
Pyxis Oncology announced that its Board of Directors has appointed Interim CEO Thomas Civik as the company's permanent Chief Executive Officer and Chairman of...
🟢 Pyxis Oncology is trading 10.38% up today with no clear catalyst identified
Pyxis Oncology is trading 10.38% up at $3.94, with no clear company-specific catalyst identified for September 4, 2026. - The latest company update concerns...
🟢 Pyxis Oncology is trading 5.41% up today with no clear catalyst identified
Pyxis Oncology is trading 5.41% up now at $3.76, with no clear catalyst identified. - No new company-specific announcement was identified on September 4,...
🔴 Pyxis Oncology is trading 5% down today after reversing biotech-led rally
Pyxis Oncology is trading at $3.56, down 5.07% after reversing an early biotech-led rally. - No new company-specific announcement, earnings release, or...
🟢 Pyxis Oncology is trading 6.4% up in pre-market amid continued biotech-sector momentum
Pyxis Oncology is trading 6.4% up at $3.99, with the move most likely reflecting continued biotech-sector momentum. - It gained 9.01% on September 2, 2026; no...
🟢 Pyxis Oncology is trading 5.7% up today as biotech sector outperforms
Pyxis Oncology is trading 5.7% higher at $3.63, with biotech-sector strength providing the strongest available explanation for the move. - Shares opened...
🔴 Pyxis Oncology is trading 10.17% down in pre-market
Pyxis Oncology is trading 10.17% down at $3.09 after falling from the September 1, 2026 close of $3.44; no clear company-specific negative announcement or...
🟢 Pyxis Oncology is trading 5.9% up today, with the conference announcement possibly supporting investor interest
Pyxis Oncology is trading at $3.43, up +5.86%, with its conference announcement a possible source of investor interest; no definitive catalyst directly...
🔴 Pyxis Oncology is trading 5% down today as broader markets weaken
Pyxis Oncology is trading 5.11% down now at $3.06 as broader markets weaken amid renewed Middle East tensions, higher oil prices, and concerns about a more...